Michigan Researchers ID Potential Glycoprotein Biomarker for Pancreatic Cancer

Researchers at the University of Michigan Comprehensive Cancer Center demonstrated that a mass spectrometric blood serum assay based on haptoglobin fucosylation patterns could become an accurate method for pancreatic cancer diagnosis.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.